1 study found for:    24021313 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus
Intervention: Biological: ChimeriVax™ Tetravalent Dengue Vaccine

Indicates status has not been verified in more than two years